Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro

Oncogene

Volumn 19, Issue 15, 2000, Pages 1891-1900

  Rudolph, Bettina ^a,b   Hueber, Anne Odile ^a,c   Evan, Gerard I ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b DeveloGen AG   (Germany)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

4 OHT; Apoptosis; Proliferation; Switchable c myc; T cell development

Indexed keywords

4 HYDROXYTAMOXIFEN; MONOCLONAL ANTIBODY CD3; MYC PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SELECTION; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0034611605     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203508     Document Type: Article

References (53)

1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD and Brinster RL. (1985). Nature, 318, 533-538.
2. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ and Giaccia AJ. (1996). Cancer Res., 56, 4315-4319.
3. Amati B, Dalton S, Brooks M, Littlewood T, Evan G and Land H. (1992). Nature, 359, 423-426.
4. Amati B and Land H. (1994). Curr. Opin. Genet. Dev., 4, 102-108.
5. Amati B, Littlewood TD, Evan GI and Land H. (1993). EMBO J., 12, 5083-5087.
6. Askew D, Ashmun R, Simmons B and Cleveland J. (1991). Oncogene, 6, 1915-1922.
7. Ayer DE, Kretzner L and Eisenman RN. (1993). Cell, 72, 211-222.
8. Bissonnette R, Echeverri F, Mahboubi A and Green D. (1992). Nature, 359, 552-554.
9. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H. (1990). Science, 250, 1149-1151.
10. Blackwood EM and Eisenman RN. (1991). Science, 251, 1211-1217.
11. Bluthmann H, Kisielow P, Uematsu Y, Malissen M, Krimpenfort P, Berns A, von Boehmer H and Steinmetz M. (1988). Nature, 334, 156-159.
12. Brinster RL, Chen HY, Trumbauer ME, Yagle MK and Palmiter RD. (1985). PNAS, 82, 4438-4442.
13. Broussard-Diehl C, Bauer SR and Scheuermann RH. (1996). J. Immunology, 156, 3141-3150.
14. Calan BJ, Szychowski S, Chan FKM, Cado D and Winoto A. (1995). Immunity. 3, 273-282.
15. Carding S and Reem GH. (1987). Thymus, 10, 219-229.
16. Chaffin KE, Beals CR, Wilkie TM, Forbusch KA, Simon MI and Perlmutter RM. (1990). EMBO J., 9, 3821-3829.
17. Cole M. (1986). Annu. Rev. Genet., 20, 361-384.
18. Davis AC, Wims M, Spotts CD, Hann SR and Bradley A. (1993). Genes Dev., 7, 671-682.
19. Eilers M, Schirm S and Bishop JM. (1991). EMBO J., 10, 133-141.
20. Evan GI, Hancock D and Littlewood T. (1985). Elsevier Sciences, Hameenlinna.
21. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 63, 119-125.
22. Fanidi A, Harrington E and Evan G. (1992). Nature, 359, 554-556.
23. Furr BJ, Patterson JS, Richardson DN and Slater SR. (1979). Pharm. Biochem. Prop. Drug Subst., 2, 355-399.
24. Harrington EA, Bennett MR, Fanidi A and Evan GI. (1994). EMBO J., 13, 3286-3295.
25. Heikkila R, Schwab G, Wickstrom E, Loke S, Pulznik D, Watt R and Neckers L. (1987). Nature, 328, 445-449.
26. Huebcr A-O, Zörnig M, Lyon D, Suda T, Nagata S and Evan G. (1997). Science, 278, 1305-1309.
27. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA and Eisenman RN. (1995). EMBO J., 14, 5646-5659.
28. Juin P, Hueber A-O, Littlewood T and Evan G. (1999). Genes Der., 13, 1367-1381.
29. Kelly K and Siebenlist U. (1986). Annu. Rev. Immunol., 4, 317-338.
30. Kisielow P, Bluethmann U, Staerz D, Steinmetz M and von Boehmer H. (1988). Nature, 333, 742.
31. Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M and Alitalo K. (1994). EMBO J., 15, 5442-5450.
32. Littlewood TD, Hancock DC, Danielian P, Parker MG and Evan GI. (1995). Nucl. Acids Res., 23, 1686-1690.
33. Lucas B, Vasseur F and Penit C. (1998). J. Immunol., 151, 4574-4582.
34. Lyons AB and Parish CR. (1994). J. Immunol. Methods, 171, 131-137.
35. Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J and Kappler JW. (1993). Immun. Rev., 131, 79-92.
36. Miyazaki T and Lemonnier FA. (1998). J. Exp. Med., 4, 715-723.
37. Pelengaris S, Littlewood T, Khan M, Elia G and Evan GI. (1999). Molec. Cell, 3, 565-577.
38. Robey EA, Ramsdell F, Gordon JW, Mamalaki C, Kioussis D, Youn HJ, Gottlieb PD, Axel R and Fowlkes BJ. (1992). Int. Immunol., 155, 969-974.
39. Sambrook J, Fritsch EF and Maniatis T. (1989). Second Edition: Cold Spring Harbor Laboratory Press.
40. Shortmun K, Egerton M, Spangrude GJ and Scollary R. (1990). Sem. Immunol., 2, 3-12.
41. Spanopoulou E, Early A, Elliot J, Crispe N, Ladyman H, Ritter M, Watt S, Grosveld F and Kioussis D. (1989). Nature, 342, 185-189.
42. Spencer CA and Groudine M. (1991). Adv. Cancer Res., 56, 1-48.
43. Stewart M, Cameron E, Campbell M, Mcfarlane R, Toth S, Lang K, Onions D and Neil JC. (1993). Int. J. Cancer, 53, 1023-1030.
44. Surh CD and Sprent J. (1994). Nature, 372, 100-103.
45. Teh HS, Kishi H, Scott B and von Boehmer H. (1989). J. Exp. Med., 169, 795-806.
46. Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H and von Boehmer H. (1988). Nature, 335, 229-233.
47. Tough D and Sprent J. (1994). J. Exp. Med., 179, 1127-1135.
48. von Boehmer H. (1990). Annu. Rev. Immunol., 8, 531-556.
49. Wagner AJ, Small MB and Hay N. (1993). Mol. Cell Biol., 13, 2432-2440.
50. Watanabe M, Tanaka H, Koizumi H, Tanimoto Y, Tony R and Yanagita T. (1980). Jitchuken Zenrinsho Kenkyyicho, 6, 1-36.
51. Wells AD, Gudmondsdottir H and Turka LA. (1997). J. Clin. Invest., 100, 3173-3183.
52. Wildin RS, Garvin AM, Pawar S, Lewis D, Abraham KM, Forbusch KA, Ziegler SF, Allen JM and Perlmutter RM. (1991). J. Exp. Med., 173, 383-393.
53. Zervos AS, Gyuris J and Brent R. (1993). Cell, 72, 223-232.